Melinda Farkas

<i>S</i>-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease

Michael Linnebank, Julius Popp, Yvo M. Smulders et al. · Neurodegenerative Diseases · 2010 · 102 citations · Full text

Medicine, Neurology, Neuroscience +13

Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern

Björn Zörner, Linard Filli, Katja Reuter et al. · Multiple Sclerosis Journal · 2016 · 48 citations

Education, Rehabilitation Medicine, Functional Movement Assessment +16

Hyperhomocysteinemia in Alzheimer's Disease: The Hen and the Egg?

Melinda Farkas, Salla Keskitalo, Desirée E.C. Smith et al. · Journal of Alzheimer s Disease · 2013 · 35 citations · Full text

Medicine, Neurobiology, Neurology +13

The variant methylenetetrahydrofolate reductase c.1298A>C (p.E429A) is associated with multiple sclerosis in a German case-control study

Luisa Klotz, Melinda Farkas, Nadja Bain et al. · Neuroscience Letters · 2009 · 29 citations

Life Sciences, Genetics, Molecular Genetics +13

Determinants of the essential one-carbon metabolism metabolites, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluid

Desirée E.C. Smith, Yvo M. Smulders, Henk J. Blom et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2012 · 28 citations

Life Sciences, Biochemistry, Neuroscience +8